These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12806170)

  • 1. Molecular binding interactions: their estimation and rationalization in QSARs in terms of theoretically derived parameters.
    Lewis DF; Broughton HB
    ScientificWorldJournal; 2002 Jun; 2():1776-802. PubMed ID: 12806170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Binding Interactions: Their Estimation and Rationalization in QSARs in Terms of Theoretically Derived Parameters.
    Lewis DFV; Broughton HB
    ScientificWorldJournal; 2002; 2():1654-1660. PubMed ID: 29973856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new method for quantitative assessment of mechanisms of partitioning and absorption of drugs: linear solvation energy relationships].
    Li J; Sun J; He ZG
    Yao Xue Xue Bao; 2007 Jan; 42(1):13-8. PubMed ID: 17520801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuum and discrete calculation of fractional contributions to solvation free energy.
    Morreale A; Gelpí JL; Luque FJ; Orozco M
    J Comput Chem; 2003 Oct; 24(13):1610-23. PubMed ID: 12926005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.
    Siraki AG; Chevaldina T; Moridani MY; O'Brien PJ
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):118-25. PubMed ID: 14982155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical study of the quantitative structure-activity relationships for the toxicity of dibenzo-p-dioxins.
    Zhao YY; Tao FM; Zeng EY
    Chemosphere; 2008 Aug; 73(1):86-91. PubMed ID: 18589475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.
    Ermondi G; Lorenti M; Caron G
    J Med Chem; 2004 Jul; 47(16):3949-61. PubMed ID: 15267234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based calculation of drug efficiency indices.
    Hetényi C; Maran U; García-Sosa AT; Karelson M
    Bioinformatics; 2007 Oct; 23(20):2678-85. PubMed ID: 17804436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin permeation rate as a function of chemical structure.
    Katritzky AR; Dobchev DA; Fara DC; Hür E; Tämm K; Kurunczi L; Karelson M; Varnek A; Solov'ev VP
    J Med Chem; 2006 Jun; 49(11):3305-14. PubMed ID: 16722649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular thermodynamic view of DNA-drug interactions: a case study of 25 minor-groove binders.
    Shaikh SA; Ahmed SR; Jayaram B
    Arch Biochem Biophys; 2004 Sep; 429(1):81-99. PubMed ID: 15288812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative correlation between theoretical molecular descriptors and drug-HSA binding affinities for various cox-2 inhibitors.
    Seedher N; Bhatia S; Singh B
    Chem Biol Drug Des; 2008 Oct; 72(4):297-302. PubMed ID: 18844676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Druggability indices for protein targets derived from NMR-based screening data.
    Hajduk PJ; Huth JR; Fesik SW
    J Med Chem; 2005 Apr; 48(7):2518-25. PubMed ID: 15801841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilicity--methods of determination and its role in medicinal chemistry.
    Rutkowska E; Pajak K; Jóźwiak K
    Acta Pol Pharm; 2013; 70(1):3-18. PubMed ID: 23610954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment-based drug design: how big is too big?
    Hajduk PJ
    J Med Chem; 2006 Nov; 49(24):6972-6. PubMed ID: 17125250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational model for the prediction of aqueous solubility that includes crystal packing, intrinsic solubility, and ionization effects.
    Johnson SR; Chen XQ; Murphy D; Gudmundsson O
    Mol Pharm; 2007; 4(4):513-23. PubMed ID: 17539661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating protein-ligand binding free energy: atomic solvation parameters for partition coefficient and solvation free energy calculation.
    Pei J; Wang Q; Zhou J; Lai L
    Proteins; 2004 Dec; 57(4):651-64. PubMed ID: 15390269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.